Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
Clinical trial NCT02697383 · COMPLETED
Trial details
- NCT number
- NCT02697383
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2024-05-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.